Surgery is a promising strategy for improving overall survival for stage III-N2 non-small cell lung cancer patients
Journal of thoracic disease(2023)
摘要
Surgery is associated with improved OS in stage III-N2 NSCLC patients and is recommended to treat these patients.
更多查看译文
关键词
Surgery,non-small cell lung cancer (NSCLC),overall survival (OS),radiotherapy,stage III-N2
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要